Atherosclerosis Forum-1
|
13:30-15:30 403 |
|---|
| 主持 Moderators | 周玉杰 Yujie ZHOU, 马晓峰 Xiaofeng MA, 王毅 Yi WANG, 金红峰 Hongfeng JIN, 裘晟 Cheng QIU, 隋向前 Xiangqian SUI | ||
|
13:30-13:50 |
GLP-1RA与ASCVD GLP-1RA and ASCVD |
李勇 Yong LI | |
|
13:50-14:10 |
CKM时代下的血脂管理策略 Lipid Management Strategy in the CKM Era |
包丽雯 Liwen BAO | |
|
14:10-14:30 |
家族性高胆固醇血症诊疗管理进展与未来展望 Progress and Future Prospects in the Diagnosis, Treatment and Management of Familial Hypercholesterolemia |
陈红 Hong CHEN | |
|
14:30-14:50 |
肥胖和心血管疾病-ESC临床指南解读 Obesity and Cardiovascular Diseases - Interpretation of ESC Clinical Guidelines |
袁祖贻 Zuyi YUAN | |
|
14:50-15:10 |
改善HDL功能可以使心血管获益吗 Can Improving HDL Function Benefit Cardiovascular Health? |
叶平 Ping YE | |
|
15:10-15:30 |
讨论 Discussion |
||
Atherosclerosis Forum-2
|
15:30-17:30 403 |
|---|
| 主持 Moderators | 孔祥清 Xiangqing KONG, 黄恺 Kai HUANG, 黄晶 Jing HUANG, 谢伟 Wei XIE, 童国新 Guoxin TONG, 李海如 Hairu LI | ||
|
15:30-15:50 |
女性特殊时期（妊娠、哺乳、围绝经期）血脂水平评估和管理 Evaluation and Management of Blood Lipid Levels in Women During Special Periods (Pregnancy, Lactation, Perimenopause) |
张大庆 Daqing ZHANG | |
|
15:50-16:10 |
神经酰胺，控制残余风险的靶标？ Ceramide: A Target for Controlling Residual Risk? |
郑金刚 Jingang ZHENG | |
|
16:10-16:30 |
中国基层血脂异常管理2024指南解读 Interpretation of the 2024 Guidelines for the Management of Dyslipidemia in Primary Care in China |
王增武 Zengwu WANG | |
|
16:30-16:50 |
冠心病抗炎治疗 Anti-Inflammatory Treatment of Coronary Heart Disease |
刘震宇 Zhenyu LIU | |
|
16:50-17:10 |
ACS血脂异常管理指南更新的思考 Reflections on the Update of Guidelines for the Management of Dyslipidemia in ACS |
杨文艺 Wenyi YANG | |
|
17:10-17:30 |
从CKM到SMD From CKM to SMD |
黄恺 Kai HUANG | |
Atherosclerosis Forum-3
|
08:00-10:00 403 |
|---|
| 主持 Moderators | 曲新凯 Xinkai QU, 陆士娟 Shijuan LU, 何正飞 Zhengfei HE, 吴斌 Bin WU, 叶军 Jun YE | ||
|
08:00-08:20 |
脂代谢紊乱与动脉粥样硬化 Lipid Metabolism Disorders and Atherosclerosis |
杨伟宪 Weixian YANG | |
|
08:20-08:40 |
HDL与心血管获益-现状与未来 HDL and Cardiovascular Benefits - Current Status and Future |
严晓伟 Xiaowei YAN | |
|
08:40-09:00 |
AS抗炎治疗的临床研究进展 Clinical Research Progress of Anti-Inflammatory Treatment for Atherosclerosis |
杨人强 Renqiang YANG | |
|
09:00-09:20 |
由表及里，GLP-1RA在ASCVD合并糖尿病治疗中的获益机制 From Surface to Essence: Benefit Mechanism of GLP-1RA in the Treatment of ASCVD Complicated with Diabetes Mellitus |
张英梅 Yingmei ZHANG | |
|
09:20-09:40 |
经脑心轴干预动脉粥样硬化疾病的探索与发现 Exploration and Discovery of Intervening Atherosclerotic Diseases Through the Brain-Heart Axis |
于雪 Xue YU | |
|
09:40-10:00 |
稳定和逆转冠状动脉粥样硬化斑块的治疗研究进展 Research Progress in the Treatment of Stabilizing and Reversing Coronary Atherosclerotic Plaques |
郭彩霞 Caixia GUO | |
Atherosclerosis Forum-4
|
10:00-12:00 403 |
|---|
| 主持 Moderators | 毛威 Wei MAO, 寿锡凌 Xiling SHOU, 黄抒伟 Shuwei HUANG, 魏文娟 Wenjuan WEI, 成银宏 Yinhong CHENG, 陈建明 Jianming CHEN | ||
|
10:00-10:20 |
从指南到临床看ASCVD血脂管理革新与变迁 Innovation and Changes in ASCVD Lipid Management from Guidelines to Clinical Practice |
李建军 Jianjun LI | |
|
10:20-10:40 |
2025ESC 血脂管理新视野：起始联合治疗的循证证据与实践 2025 ESC New Horizons in Lipid Management: Evidence and Practice of Initial Combination Therapy |
徐标 Biao XU | |
|
10:40-11:00 |
从“心肾代谢综合征”新理念，探寻疾病综合管理之路 Exploring Integrated Disease Management: Insights from the Novel Concept of Cardiorenal Metabolic Syndrome |
王连生 Liansheng WANG | |
|
11:00-11:20 |
LP（a）-降脂领域的下一个热点？ LP (a) - The Next Hot Topic in Lipid-Lowering Field? |
黄进宇 Jinyu HUANG | |
|
11:20-11:40 |
从指南更新看 ACS 患者降脂达标管理 Lipid Management in ACS: Insights from Guideline Updates |
胡惠林 Huilin HU | |
|
11:40-12:00 |
从指南更新看 CCS 患者降脂达标策略 Lipid-Lowering Target Achievement Strategy for CCS Patients from the Perspective of Guideline Updates |
梅益斌 Yibin MEI | |
Metabolic & CVD Forum-1
|
13:30-15:30 403 |
|---|
| 主持 Moderators | 李浪 Lang LI, 王长谦 Changqian WANG, 王永光 Yongguang WANG, 李小成 Xiaocheng LI | ||
|
13:30-13:50 |
心血管疾病合并慢性肾脏病早期筛查及规范管理专家共识解读 Interpretation of the Expert Consensus on Early Screening and Standardized Management of Cardiovascular Disease Complicated by Chronic Kidney Disease |
陈纪言 Jiyan CHEN | |
|
13:50-14:10 |
GLP-1受体激动剂：超越降糖的心血管获益新纪元/心肾代谢综合征的整合管理 GLP-1 Receptor Agonists: A New Era of Cardiovascular Benefits Beyond Glycemic Control / Integrated Management of Cardiorenal Metabolic Syndrome |
郑杨 Yang ZHENG | |
|
14:10-14:30 |
射血分数保留的心衰患者治疗进展 Advances in the Treatment of Heart Failure with Preserved Ejection Fraction |
吴高俊 Gaojun WU | |
|
14:30-14:50 |
CKM与颈动脉体—机制与干预 CKM and the Carotid Body: Mechanisms and Interventions |
黄晶 Jing HUANG | |
|
14:50-15:10 |
器官交互与代谢衰老 Organ Crosstalk and Metabolic Aging |
陆熙园 Xiyuan LU | |
|
15:10-15:30 |
心血管代谢学：从学科构建到临床实践的演进/冠心病合并代谢紊乱的介入治疗策略 Cardiometabolic Medicine: Evolution from Discipline Development to Clinical Practice / Interventional Strategies for Coronary Artery Disease with Metabolic Disorders |
唐熠达 Yida TANG | |
Metabolic & CVD Forum-2
|
15:30-17:30 403 |
|---|
| 主持 Moderators | 董建增 Jianzeng DONG, 宋雷 Lei SONG, 柴东升 Dongsheng CHAI, 李亚 Ya LI, 江帆 Fan JIANG, 刘强 Qiang LIU | ||
|
15:30-15:50 |
TBD | 定 待 | |
|
15:50-16:10 |
慢性炎症、肠道菌群与动脉粥样硬化 Chronic Inflammation, Gut Microbiota, and Atherosclerosis |
耿兆红 Zhaohong GENG | |
|
16:10-16:30 |
GLP-1RA在肥胖合并HFpEF中的研究进展 Research Progress on GLP-1 Receptor Agonists in Obesity with Heart Failure with Preserved Ejection Fraction (HFpEF) |
寿锡凌 Xiling SHOU | |
|
16:30-16:50 |
舒张期高血压和代谢综合征 Diastolic Hypertension and Metabolic Syndrome |
谢良地 Liangdi XIE | |
|
16:50-17:10 |
动脉粥样硬化抗炎症治疗 Anti-inflammatory Therapy for Atherosclerosis |
车文良 Wenliang CHE | |
|
17:10-17:30 |
⼈⼯⾎管研究进展 Progress in Artificial Vascular Grafts |
孔德领 Deling KONG | |
Zhejiang-Xiangya Joint Forum-1
|
08:00-10:00 403 |
|---|
| 主席 Chairmen | 王建安 Jianan WANG, 柏勇平 Yongping BAI | ||
| 主持 Moderators | 李长岭 Changling LI, 陈雯艾 Wenai CHEN | ||
|
08:00-08:20 |
肿瘤与心血管疾病相关性的思索 Cardio-Oncology: Current Insights and Future Directions |
张国刚 Guogang ZHANG | |
|
08:20-08:40 |
ASCVD创新治疗进展 Innovative Therapeutic Advances in ASCVD |
柏勇平 Yongping BAI | |
|
08:40-09:00 |
代谢性疾病与房颤 Metabolic Disorders and Atrial Fibrillation: An Interrelationship |
刘启明 Qiming LIU | |
|
09:00-09:20 |
新型降压药物新进展 Recent Advances in Novel Antihypertensive Agents |
蒋卫红 Weihong JIANG | |
|
09:20-09:40 |
药物负荷超声在冠脉微血管疾病中的诊断价值和进展 The Diagnostic Value and Evolving Role of Pharmacologic Stress Echocardiography in Coronary Microvascular Disease |
马琦琳 Qilin MA | |
|
09:40-10:00 |
动脉粥样硬化心血管疾病早期靶向诊断与治疗进展 Advances in Early Targeted Diagnosis and Treatment of Atherosclerotic Cardiovascular Disease |
傅国胜 Guosheng FU | |
Zhejiang-Xiangya Joint Forum-2
|
10:00-12:00 403 |
|---|
| 主席 Chairmen | 张国刚 Guogang ZHANG, 刘启明 Qiming LIU | ||
| 主持 Moderators | 蒋峻 Jun JIANG, 夏淑东 Shudong XIA, 黄翯 He HUANG, 何玉虎 Yuhu HE | ||
|
10:00-10:20 |
PFA 临床应用及思考 Pulsed Field Ablation in Clinical Practice: Applications and Insights |
石瑞正 Ruizheng SHI | |
|
10:20-10:40 |
高血压靶器官保护的免疫调节新机制 Novel Immunomodulatory Mechanisms in Hypertensive Target Organ Protection |
徐虎 Hu XU | |
|
10:40-11:00 |
血管外膜淋巴网络与血管重构 The Adventitial Lymphatic Network and Vascular Remodeling |
蔡菁菁 Jingjing CAI | |
|
11:00-11:20 |
血压变异性与心血管疾病风险：临床研究进展 Blood Pressure Variability and Cardiovascular Disease: Advances in Clinical Research |
程勋杰 Xunjie CHENG | |
|
11:20-11:40 |
胆固醇代谢在侧支循环中的研究进展 The Role of Cholesterol Metabolism in Collateral Circulation: Recent Advances |
朱灵萍 Lingping ZHU | |
|
11:40-12:00 |
2025美国ACS指南的启示 Implications of the 2025 U.S. Acute Coronary Syndromes (ACS) Guidelines |
朱建华 Jianhua ZHU | |